NDLI: Care for patients with multiple endocrine neoplasia type 1: the current evidence base

Please wait, while we are loading the content...

Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress

Two BRCA1/2 founder mutations in Jews of Sephardic origin

A new mutation of BRCA2 gene in an Italian healthy woman with familial breast cancer history

Strictly defined familial male breast cancer

What I wish I’d known before surgery: BRCA carriers’ perspectives after bilateral salipingo-oophorectomy

A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives

An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations

Gene expression in response to ionizing radiation and family history of gastric cancer

Genetic epidemiological analysis reveals a multi-gene additive model for gastric cancer

Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis

An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models

Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor

Cancer survivors: familial risk perception and management advice given to their relatives

Care for patients with multiple endocrine neoplasia type 1: the current evidence base

Familial Cancer : Volume 9

Familial Cancer : Volume 8

Familial Cancer : Volume 7

Familial Cancer : Volume 6

Familial Cancer : Volume 5

Familial Cancer : Volume 4

Familial Cancer : Volume 3

Familial Cancer : Volume 2

Familial Cancer : Volume 1

Care for patients with multiple endocrine neoplasia type 1: the current evidence base

Content Provider	Springer Nature Link
Author	Pieterman, C. R. C. Vriens, M. R. Dreijerink, K. M. A. Luijt, R. B. Valk, G. D.
Copyright Year	2010
Abstract	Multiple endocrine neoplasia type 1 (MEN1) is a rare disease caused by mutations in the MEN1 gene on chromosome 11. It is characterized by the occurrence of primary hyperparathyroidism (pHPT), duodenopancreatic neuroendocrine tumours (pNET), pituitary tumours (PIT), adrenal adenomas (ADR) and neuroendocrine tumours (NET) of the stomach, bronchus and thymus. MEN1 is a syndrome with high penetrance and high morbidity. Malignant NETs are the most important cause of MEN1-related death. Since 1997 the diagnosis can be made by genetic screening. MEN1 is a complex syndrome and the endocrine manifestations cannot be viewed upon as coinciding sporadic tumours. Differences in epidemiology and pathology between MEN1-related tumours and their sporadic counterparts show that a unique approach is needed. Therefore the care for MEN1 patients should be provided by a centre of expertise. Early genetic diagnosis and periodic screening are important pillars of care. For primary hyperparathyroidism surgery is the most important treatment modality, with a subtotal parathyroid gland resection as the procedure of choice. In neuroendocrine tumours surgery also is the most important treatment modality. Selective tumour enucleation has no place in the surgical treatment of MEN1-related pNETs; the exact procedure depends on the functionality of the tumour. In MEN1-associated pituitary and adrenal adenomas, watchful waiting and medical therapy play more important roles. In the twenty-first century new developments will impact the care for MEN1 patients. These developments should be critically evaluated in clinical research with the ultimate goal of optimizing the care for MEN1 patients on an evidence base.
Starting Page	157
Ending Page	171
Page Count	15
File Format	PDF
ISSN	13899600
Journal	Familial Cancer
Volume Number	10
Issue Number	1
e-ISSN	15737292
Language	English
Publisher	Springer Netherlands
Publisher Date	2010-11-09
Publisher Place	Dordrecht
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Adrenal adenomas Follow-up Multiple endocrine neoplasia type 1 Neuroendocrine tumours Outcome Pituitary tumours Prevention hyperparathyroidism Screening Treatment Biomedicine general Epidemiology Human Genetics Cancer Research
Content Type	Text
Resource Type	Article
Subject	Genetics Cancer Research Genetics (clinical) Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients

Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?

Multiple endocrine neoplasia 1: a broad overview

Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India

Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1

Update multiple endocrine neoplasia type 2

Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman

The Outcome of Subtotal Parathyroidectomy for the Treatment of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1

Subtotal Parathyroidectomy as an Adequate Treatment for Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1

Care for patients with multiple endocrine neoplasia type 1: the current evidence base

Similar Documents

Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients

Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?

Multiple endocrine neoplasia 1: a broad overview

Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India

Outcome and long-term follow-up of adrenal lesions in multiple endocrine neoplasia type 1

Update multiple endocrine neoplasia type 2

Atypical ovarian carcinoid tumor with widespread skeletal metastases: a case report of multiple endocrine neoplasia type 1 in a young woman

The Outcome of Subtotal Parathyroidectomy for the Treatment of Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1

Subtotal Parathyroidectomy as an Adequate Treatment for Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1

Care for patients with multiple endocrine neoplasia type 1: the current evidence base